EICHORPublic-registry site landscape for NCT03838133, “A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy”, a Hallux Valgus study sponsored by Taiwan Liposome Company. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03838133 (registry record) |
| Study title | A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy |
| Official title | A Phase 2, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy |
| Sponsor | Taiwan Liposome Company |
| Condition(s) | Hallux Valgus |
| Phase | PHASE2 |
| Listed sites | 5 |
| Intervention(s) | TLC590, Naropin®, Normal Saline, Bupivacaine |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT03838133.
Eichor generates a preliminary site-risk snapshot for NCT03838133 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
